ESMO Guidelines: Real World Cases – Webinar Series: Venous
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Cancer-associated fibroblasts (CAFs) exhibit spatial and functional diversity. Here, Niu et al. unveil SETD2’s function in lipid metabolism and CAF heterogeneity in pancreatic ductal adenocarcinoma. SETD2…
Anne Chiang, MD, PhD, discusses understanding the heterogeneity of SCLC to determine which patients will respond to targeted therapy.
A nipple delay is a procedure, typically used with a nipple-sparing mastectomy, that aims to save the nipple during breast cancer surgery.
It’s been inspiring – and humbling – to get to know the 40 young leaders in this year’s class. I recommend we all keep an…
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
Expert insights into the evolving therapeutic landscape for early-stage breast cancers, emphasizing targeted therapies and genomic testing for personalized treatment paradigms.
During a Case-Based Roundtable® event, Natalia Neparidze, MD, discussed the studies that led to accelerated approval of the bispecific T-cell engagers teclistamab and elranatamab in…
This Viewpoint discusses use of anti–PD-1 monotherapy as the primary treatment option for patients with treatment-naive metastatic melanoma staining positive for PD-L1 over dual checkpoint…
If you have had a biopsy or surgery that removes tissue from your body, in almost all cases a sample will be sent to a…
At a median follow-up of 18.1 months, the ORR and CR rates were both 95.7% following liso-cel treatment.